MAXIMIZING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

from the rapidly evolving industry of oncology research, exact and efficient mutation screening is very important for establishing qualified therapies. The KRAS solutions Platform performs a pivotal position On this landscape by offering complete options for KRAS mutation profiling and Examination. KRAS mutations, found in close to ninety five% of